3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
2
Sponsor
Cancer Type
Myeloid
2
Conditions
Primary Myelofibrosis
1
Polycythemia Vera
1
Bone Marrow Neoplasms
1
Interventions
Surveys and Questionnaires
38
Blood Specimen Collection
24
Specimen Handling
14
Radiotherapy
12
Surgical Procedures, Operative
10
Interviews as Topic
10
Observation
9
Magnetic Resonance Spectroscopy
9
Drug Therapy
9
Data Collection
8
Immunotherapy
7
Watchful Waiting
5
Tomography, X-Ray Computed
5
Radiosurgery
5
Nivolumab
5
Mastectomy, Segmental
5
Biopsy
5
ribociclib
4
palbociclib
4
Therapeutics
4
Positron Emission Tomography Computed Tomography
4
Mental Status and Dementia Tests
4
Magnetic Resonance Imaging
4
Ipilimumab
4
Immune Checkpoint Inhibitors
4
High-Throughput Nucleotide Sequencing
4
Echocardiography
4
Bevacizumab
4
lorlatinib
3
atezolizumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Observational
×
Hydroxyurea
×
Clear all
NCT04217356
2026-01-26
ALLO-BAT
University Health Network, Toronto
Active not recruiting
90 enrolled
NCT05548062
2025-09-03
Prospero
Novartis
Active not recruiting
242 enrolled